Insulet Corp. (PODD)
138.06
+2.78
(+2.05%)
USD |
NASDAQ |
Oct 12, 14:17
Insulet Free Cash Flow (Quarterly) : 51.20M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 51.20M |
| March 31, 2026 | 86.00M |
| December 31, 2025 | 33.90M |
| September 30, 2025 | 94.60M |
| June 30, 2025 | 173.30M |
| March 31, 2025 | 48.10M |
| December 31, 2024 | 91.70M |
| September 30, 2024 | 69.40M |
| June 30, 2024 | 71.60M |
| March 31, 2024 | 63.60M |
| December 31, 2023 | 13.30M |
| September 30, 2023 | 33.60M |
| June 30, 2023 | 25.90M |
| March 31, 2023 | -36.60M |
| December 31, 2022 | -37.70M |
| September 30, 2022 | 22.80M |
| June 30, 2022 | 6.20M |
| March 31, 2022 | -29.60M |
| December 31, 2021 | -62.40M |
| September 30, 2021 | -55.00M |
| June 30, 2021 | -4.90M |
| March 31, 2021 | -68.50M |
| December 31, 2020 | -70.70M |
| September 30, 2020 | 17.60M |
| June 30, 2020 | 1.60M |
| Date | Value |
|---|---|
| March 31, 2020 | -31.00M |
| December 31, 2019 | -2.992M |
| September 30, 2019 | 7.129M |
| June 30, 2019 | -32.78M |
| March 31, 2019 | -38.89M |
| December 31, 2018 | -4.356M |
| September 30, 2018 | -21.77M |
| June 30, 2018 | -60.69M |
| March 31, 2018 | -39.64M |
| December 31, 2017 | -7.613M |
| September 30, 2017 | 14.53M |
| June 30, 2017 | 4.575M |
| March 31, 2017 | -47.51M |
| December 31, 2016 | 17.16M |
| September 30, 2016 | -10.62M |
| June 30, 2016 | 0.936M |
| March 31, 2016 | -13.68M |
| December 31, 2015 | -22.08M |
| September 30, 2015 | 6.221M |
| June 30, 2015 | 0.53M |
| March 31, 2015 | -7.834M |
| December 31, 2014 | 1.974M |
| September 30, 2014 | 1.714M |
| June 30, 2014 | -3.08M |
| March 31, 2014 | -3.174M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Boston Scientific Corp. | 1.279B |
| DexCom, Inc. | 184.50M |
| PROCEPT BioRobotics Corp. | -22.20M |
| Abbott Laboratories | 1.991B |
| The Cooper Cos., Inc. | 273.00M |